Ribas A, Hanson DC, Noe DA, et al. Tremelimumab (CP -675,206), a cy totoxic T lymphocy te associated antigen 4 blocking monoclonal antibody in clinical development for patients with cancer. Oncologist 2007;12(7):873-83.